论文部分内容阅读
目的观察尼莫地平治疗原发性高血压的临床疗效。方法选择原发性高血压患者96例随机分为观察组和对照组,观察组服用尼莫地平,对照组服用硝苯地平,均4周为1个疗程。结果观察组总有效率为93.75%,对照组总有效率为91.67%。治疗后观察组与对照组血压比较差异无统计学意义(P>0.05),但与治疗前比较差异有统计学意义(P<0.05)。结论尼莫地平治疗原发性高血压疗效满意,不良反应小,是理想的降压药物。
Objective To observe the clinical efficacy of nimodipine in the treatment of essential hypertension. Methods Ninety-six patients with essential hypertension were randomly divided into observation group and control group, nimodipine in observation group and nifedipine in control group. Each group was given a course of treatment for 4 weeks. Results The total effective rate was 93.75% in the observation group and 91.67% in the control group. After treatment, there was no significant difference in blood pressure between the observation group and the control group (P> 0.05), but there was a significant difference between before and after treatment (P <0.05). Conclusion Nimodipine is an ideal antihypertensive drug for the treatment of essential hypertension with satisfactory efficacy and small adverse reactions.